Sun Pharma Advanced Research Company informs about press release

10 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it attached a Press Release on December 10, 2021 titled ‘SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting’.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

122.90 -0.60 (-0.49%)
05-Mar-2026 12:47 View Price Chart
Peers
Company Name CMP
Syngene Internation. 400.35
Indegene 461.60
CMS Info Systems 299.05
JITF Infralogistics 343.00
Sagility 39.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×